What is the rationale for using 'Dual Antiplatelet Therapy' (DAPT) in patients following coronary stent placement?
Show answer and explanation
Correct answer: To synergistically inhibit platelet activation through two pathways
DAPT, typically involving Aspirin and a P2Y12 inhibitor, targets both the Thromboxane A2 and ADP pathways. This combination provides superior prevention of stent thrombosis compared to using either agent alone.
Keep practicing
More Antiplatelet Drugs questions
- Which of the following agents is a synthetic heptapeptide that reversibly inhibits the Glycoprotein IIb/IIIa receptor?
- How long before an elective surgery should Aspirin typically be discontinued to allow for the restoration of normal platelet function?
- Cilostazol is primarily indicated for the treatment of which condition?
- Which antiplatelet drug can cause a rare but serious side effect known as Thrombotic Thrombocytopenic Purpura (TTP)?
- What is the primary effect of Thromboxane A2 (TXA2) on blood vessels?
- Which P2Y12 inhibitor is available in an intravenous formulation for rapid platelet inhibition during PCI?